GlassScriptPhysician profile
Andre Critsinelis
NPI 1689136590
$10,709.71
in general payments reported to CMS, 2019-2025
21 companies · $8,046 in 2025
The $8,046 reported for 2025 was more than what 89% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $319 · 2023: $119 · 2024: $2,226 · 2025: $8,046.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,353 · Education: $941 · Travel and Lodging: $96.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,353.17 |
| Education | $941.07 |
| Travel and Lodging | $96.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,675.20 | 2025 | Gore Tag Conformable Thoracic Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Medtronic, INC. | $1,301.05 | 2022-2025 | Endurant Iis, Hawkone, Abre |
| Bolton Medical INC | $1,243.94 | 2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System, Gelweave |
| Silk Road Medical, INC. | $1,151.39 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Shockwave Medical, INC | $1,005.69 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Endologix LLC | $791.11 | 2025 | Alto Abdominal Stent Graft System |
| Penumbra, INC. | $499.19 | 2025 | Penumbra System, Indigo System, Ruby Coil |
| Terumo Medical Corporation | $392.81 | 2024-2025 | Azur Cx Detachable, Glidesheath Slender |
| Boston Scientific Corporation | $331.42 | 2025 | General - Vascular Intervention, Enroute Transcarotid Neuroprotection System, Ekosonic |
| Polynovo North America LLC | $331.16 | 2025 | Novosorb Btm |
| Cook Medical LLC | $262.83 | 2025 | Zilver Ptx, Zenith, Zenith Spiral-Z |
| Artivion, INC. | $195.14 | 2025 | Vascular, Bioglue Surgical Adhesive, Photofix Decellularized Bovine Pericardium |
| Inspiremd LTD | $141.57 | 2025 | Cguard Prime Carotid Stent System |
| Cvrx, INC. | $127.53 | 2025 | Barostim Neo System |
| Imperative Care, INC | $67.39 | 2025 | Symphony Catheter |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $47.76 | 2025 | Esprit |
| Stryker Corporation | $37.35 | 2025 | Limflow System |
| Acera Surgical, INC. | $36.09 | 2025 | Restrata Wound Matrix |
| Reflow Medical INC | $34.29 | 2025 | |
| Lemaitre Vascular, INC. | $20.35 | 2025 | Artegraft Vascular Graft |
| Kci USA, INC. | $16.45 | 2023 | V.A.C. Veraflo Cleanse Choice, Prevena, Abthera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Critsinelis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.